Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ningbo Runhe High-Tech Materials Co., Ltd. (300727.SZ)
Ningbo, ZJ, CN
Ningbo Runhe High-Tech Materials Co., Ltd. engages in the research, production, and application of silicon new materials and textile chemicals in China and internationally. Its products include silicone oil for personal care products, defoamer, silicone leveling agent, agricultural spray adjuvant, agricultural silicone spreading and penetrating agent, single end and dual end hydrogen silicone oil, methyl terminated hydrogen branched silicone oil, and vinyl silicone oil; and liquid silicon rubber for screen printing, scutcheon, textile belt, and socks, as well as insulator liquid silicone rubber. The company also offers multicomponent copolymerization epoxy silicone oil; dyeing and finishing agent; and raw materials, including hexamethyldisiloxane and methyl hydrogen silicon oil. Ningbo Runhe High-Tech Materials Co., Ltd. was founded in 2000 and is based in Ningbo, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.17% | +0.08% | +4.92% | -4.78% | +4.92% | +0.62% | +34.41% | +74.08% | +92.59% | +404.36% | +404.36% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-07 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+6.2% ★ Q1'26: +31.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+15.5% ★ Q1'26: +7.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-0.5% Q1'26: +3.8% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+10.0% ★ Q1'26: +7.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+12.2% ★ Q1'26: +10.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+7.5% Q1'26: +4.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.01× ★ Q1'26: 0.01× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
1.10B
est: 1.21B (-8.5%)
|
1.18B
est: 1.24B (-4.8%)
|
1.14B
est: 1.24B (-8.6%)
|
1.33B
est: 1.27B (+4.3%)
|
1.41B
est: 1.40B (+0.6%)
|
1.70B
1.70B – 1.70B
+21.5% YoY
|
1.91B
1.84B – 1.98B
+12.2% YoY
|
2.11B
2.11B – 2.11B
+10.2% YoY
|
| EBITDA |
131.39M
est: 144.70M (-9.2%)
|
137.28M
est: 152.22M (-9.8%)
|
142.66M
est: 152.22M (-6.3%)
|
163.21M
est: 156.05M (+4.6%)
|
182.19M
est: 171.86M (+6.0%)
|
208.76M
208.76M – 208.76M
+21.5% YoY
|
234.26M
225.86M – 242.65M
+12.2% YoY
|
258.04M
258.04M – 258.04M
+10.2% YoY
|
| EBIT |
109.77M
est: 114.52M (-4.1%)
|
111.50M
est: 120.81M (-7.7%)
|
108.14M
est: 120.81M (-10.5%)
|
129.03M
est: 123.85M (+4.2%)
|
141.38M
est: 136.40M (+3.7%)
|
165.68M
165.68M – 165.68M
+21.5% YoY
|
185.92M
179.25M – 192.58M
+12.2% YoY
|
204.79M
204.79M – 204.79M
+10.2% YoY
|
| Net Income |
93.03M
est: 77.61M (+19.9%)
|
90.14M
est: 120.09M (-24.9%)
|
82.21M
est: 120.09M (-31.5%)
|
96.24M
est: 146.27M (-34.2%)
|
119.97M
est: 154.27M (-22.2%)
|
163.24M
163.24M – 163.24M
+5.8% YoY
|
186.56M
186.56M – 186.56M
+14.3% YoY
|
222.44M
222.44M – 222.44M
+19.2% YoY
|
| SGA |
101.04M
est: 77.80M (+29.9%)
|
113.39M
est: 119.09M (-4.8%)
|
136.06M
est: 119.09M (+14.3%)
|
148.47M
est: 122.08M (+21.6%)
|
85.17M
est: 134.45M (-36.7%)
|
163.32M
163.32M – 163.32M
+21.5% YoY
|
183.26M
176.70M – 189.83M
+12.2% YoY
|
201.87M
201.87M – 201.87M
+10.2% YoY
|
| EPS |
0.56
est: 0.61 (-7.8%)
|
0.55
est: 0.67 (-17.8%)
|
0.49
est: 0.67 (-26.8%)
|
0.58
est: 0.82 (-28.9%)
|
0.67
est: 0.86 (-22.1%)
|
0.91
0.91 – 0.91
+5.8% YoY
|
1.04
1.04 – 1.04
+14.3% YoY
|
1.24
1.24 – 1.24
+19.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bi Rong Pi | Deputy General Manager | — | female |
| Caijuan Yu | Deputy General Manager | — | female |
| Hai Ya Li | Accounting Supervisor | — | — |
| Jianping Ye | Non-Independent Chairman & GM | — | male |
| Run Min Zhu | Deputy General Manager | — | male |
| Xiaojun Xu | Deputy GM & Secretary | — | male |
| Yinchu Chai | Chief Financial Officer, Deputy GM & Non-Independent Director | — | male |
| Yu Chen | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300727.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
